Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials

Mark Nelson, Miklos Salgo, Benoît Trottier et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005

Cited by 151